Skip to main content

Advertisement

ADVERTISEMENT

Department

Formulary Frontlines®
07/20/2018
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don...
07/20/2018
First Report Managed Care
Conference Insider
07/19/2018
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of...
07/19/2018
First Report Managed Care

Advertisement

Conference Insider
07/19/2018
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to...
07/19/2018
First Report Managed Care

Advertisement

Conference Insider
07/19/2018
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018...
07/19/2018
First Report Managed Care

Advertisement

Conference Insider
07/19/2018
Recent research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that over the past decade joint replacement surgeries for rheumatoid arthritis (RA) have decreased significantly. 
Recent research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that over the past decade joint replacement surgeries for rheumatoid arthritis (RA) have decreased significantly. 
Recent research presented at the...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018...
07/19/2018
First Report Managed Care

Advertisement